Figure 1From: The cardiovascular safety of incretin-based therapies: a review of the evidenceMechanisms underlying the putative cardiovascular effects of incretin-based therapies. ANP, atrial natriuretic peptide, IR, ischaemia-reperfusion.Back to article page